Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia

Cardiovascular disease (CVD) is the most common cause of death in a global scale and significantly depends on the elevated plasma levels of low-density lipoprotein cholesterol (LDL-C) and the subsequent formation of atherosclerotic plaques. While physicians have several LDL-C-lowering agents with di...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmas, Constantine E, Bousvarou, Maria D, Sourlas, Andreas, Papakonstantinou, Evangelia J, Peña Genao, Edilberto, Echavarria Uceta, Rogers, Guzman, Eliscer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300746/
https://www.ncbi.nlm.nih.gov/pubmed/35873366
http://dx.doi.org/10.2147/CPAA.S345072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300746/
https://www.ncbi.nlm.nih.gov/pubmed/35873366
http://dx.doi.org/10.2147/CPAA.S345072

Ejemplares similares